Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Annual breast cancer screening beginning at 40 saves lives

Written by | 23 Feb 2024

Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks, according to a… read more.

Mini TEE ultrasound transducer has FDA 510 (k) approval to improve cardiac care for more patients – Royal Philips

Written by | 11 Feb 2024

Royal Philips a global leader in health technology, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has received FDA 510(k) clearance…. read more.

CT scan is most effective to assess people with chest pain

Written by | 3 Feb 2024

Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease. Recent randomized clinical… read more.

Ultrafast laser technology could offer improved cancer treatment

Written by | 20 Dec 2023

Ultrafast laser technology continues to surprise. While research in this field may seem rather abstract at first glance, it very often leads to concrete applications. This is particularly… read more.

Some breast cancer survivors may safely de-escalate mammography three years after surgery

Written by | 11 Dec 2023

Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography, according… read more.

Bendy X-ray detectors could revolutionize cancer treatment

Written by | 8 Nov 2023

New materials developed at the University of Surrey could pave the way for a new generation of flexible X-ray detectors, with potential applications ranging from cancer treatment to… read more.

CHMP positive for Elucirem (gadopiclenol) in the European Union (EU) for use in adults and children aged 2 years and over for MRI with contrast enhancement – Guerbet S.A + Bracco

Written by | 19 Oct 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion concerning the granting of a marketing authorisation for… read more.

Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction

Written by | 3 Oct 2023

Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and… read more.

More cases of breast cancer detected with the help of AI

Written by | 12 Sep 2023

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet… read more.

AI performs comparably to human readers of mammograms

Written by | 11 Sep 2023

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their… read more.

MRI scans improve prostate cancer diagnosis in screening trial

Written by | 25 Aug 2023

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard… read more.

Proton radiotherapy to treat oesophageal cancer

Written by | 19 Aug 2023

A 67-year old patient presenting with oesophageal cancer was treated today at the Paul Scherrer Institute PSI with a form of radiation provided by protons, i.e. positively charged… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.